Should Biotechnology Stock LogicBio Therapeutics Inc (LOGC) Be in Your Portfolio Tuesday?

Tuesday, November 15, 2022 11:15 AM | InvestorsObserver Analysts

Mentioned in this article

Should Biotechnology Stock LogicBio Therapeutics Inc (LOGC) Be in Your Portfolio Tuesday?

LogicBio Therapeutics Inc (LOGC) is around the top of the Biotechnology industry according to InvestorsObserver. LOGC received an overall rating of 80, which means that it scores higher than 80 percent of all stocks. LogicBio Therapeutics Inc also achieved a score of 95 in the Biotechnology industry, putting it above 95 percent of Biotechnology stocks. Biotechnology is ranked 33 out of the 148 industries.

LOGC has an Overall Score of 80. Find out what this means to you and get the rest of the rankings on LOGC!

See Full LOGC Report

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With LogicBio Therapeutics Inc Stock Today?

LogicBio Therapeutics Inc (LOGC) stock is trading at $2.07 as of 10:38 AM on Tuesday, Nov 15, a gain of $0.01, or 0.49% from the previous closing price of $2.06. The stock has traded between $2.06 and $2.07 so far today. Volume today is less active than usual. So far 91,854 shares have traded compared to average volume of 450,495 shares. Click Here to get the full Stock Report for LogicBio Therapeutics Inc stock.